• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

CVM SCIENTISTS WIN AWARDS - July/August 2002

FDA Veterinarian Newsletter 2002 Volume XVI, No IV

At the 2002 FDA Scientific Achievement Awards Ceremony, held on February 21, 2002, the following CVM scientists were recognized:

  • EXCELLENCE IN ANALYTICAL SCIENCE
    Raafat Fahmy, Ph.D. - For excellence in developing novel methods for the dissolution of aspirin, sulfas and tetracycline boluses, a unique dosage form, using standard USP apparatus and environmentally sound solvents.
  • EXCELLENCE IN LABORATORY SCIENCE
    Patrick F. McDermott, Ph.D.
    - For demonstrating the impact the use of fluoroquinolones in chickens has on the selection for fluoroquinolone resistant Campylobacter.
  • EXCELLENCE IN REVIEW SCIENCE
    Tania Denise Woerner, V.M.D.
    - Dr. Woerner utilized a novel approach to corroborate the findings of a clinical study for the approval of ponazuril to treat Equine Protozoal Myeloencephalitis (EPM).
  • OUTSTANDING INTER-CENTER SCIENTIFIC COLLABORATION
    Phenylbutazone Residue Group - ORA
    Denver District Laboratory

    • Karen S. Kreuzer
    • Mark R. Madson
    • Sherri B. Turnipseed, Ph.D.
    • Susan B. Clark
    • Gene J. Nandrea
    • William B. Martin, Ph.D.
    • W. Douglas Rowe
    • Lara L. Murphy
    • John N. Sofos


    Seattle Regional Laboratory

    • Jeffrey A. Hurlbut, Ph.D.

    CVM

    • Deborah A. Cera
    • John O'Rangers, Ph.D.
    • Michael H. Thomas
    • Mary C. Carson, Ph.D.
    • David N. Heller

For protection of the Public's Health through the reduction of Phenylbutazone abuse in food-producing animals through analytical surveillance, education and regulatory actions.

CVM is proud of these accomplishments and congratulates all FDA award winners.